Cite
Ceftaroline-associated Encephalopathy in Patients With Severe Renal Impairment
MLA
Sean Chow, et al. “Ceftaroline-Associated Encephalopathy in Patients With Severe Renal Impairment.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 70, no. 9, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e518af407e93eef06652e10bf055be5&authtype=sso&custid=ns315887.
APA
Sean Chow, Sanjay Mehta, Thomas C S Martin, & Scott T Johns. (2019). Ceftaroline-associated Encephalopathy in Patients With Severe Renal Impairment. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 70(9).
Chicago
Sean Chow, Sanjay Mehta, Thomas C S Martin, and Scott T Johns. 2019. “Ceftaroline-Associated Encephalopathy in Patients With Severe Renal Impairment.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 70 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e518af407e93eef06652e10bf055be5&authtype=sso&custid=ns315887.